|
1
|
Alessi DR, Sakamoto K and Bayascas JR:
LKB1-dependent signaling pathways. Annu Rev Biochem. 75:137–163.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hardie DG: AMP-activated/SNF1 protein
kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell
Biol. 8:774–785. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu W, Monahan KB, Pfefferle AD, Shimamura
T, Sorrentino J, Chan KT, Roadcap DW, Ollila DW, Thomas NE,
Castrillon DH, et al: LKB1/STK11 inactivation leads to expansion of
a prometastatic tumor subpopulation in melanoma. Cancer Cell.
21:751–764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han Li F, Li X, Wang F, Wang R, Gao H,
Wang Y, Fang X, Zhang Z, Yao WS, et al: LKB1 Inactivation elicits a
redox imbalance to modulate non-small cell lung cancer plasticity
and therapeutic response. Cancer Cell. 27:698–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herrmann JL, Byekova Y, Elmets CA and
Athar M: Liver kinase B1 (LKB1) in the pathogenesis of epithelial
cancers. Cancer Lett. 306:1–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bardeesy N, Sinha M, Hezel AF, Signoretti
S, Hathaway NA, Sharpless NE, Loda M, Carrasco DR and DePinho RA:
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis
but resistance to transformation. Nature. 419:162–167. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jeon SM, Chandel NS and Hay N: AMPK
regulates NADPH homeostasis to promote tumour cell survival during
energy stress. Nature. 485:661–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martinez-Lopez N, Garcia-Rodriguez JL,
Varela-Rey M, Gutiérrez V, Fernández-Ramos D, Beraza N, Aransay AM,
Schlangen K, Lozano JJ, Aspichueta P, et al: Hepatoma cells from
mice deficient in glycine N-methyltransferase have increased RAS
signaling and activation of liver kinase B1. Gastroenterology.
143:787–798.e13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SW, Li CF, Jin G, Cai Z, Han F, Chan
CH, Yang WL, Li BK, Rezaeian AH, Li HY, et al: Skp2-dependent
ubiquitination and activation of LKB1 is essential for cancer cell
survival under energy stress. Mol Cell. 57:1022–1033. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang Y-H, Chen Z-K, Huang K-T, Li P, He
B, Guo X, Zhong JQ, Zhang QY, Shi HQ, Song QT, et al: Decreased
expression of LKB1 correlates with poor prognosis in hepatocellular
carcinoma patients undergoing hepatectomy. Asian Pac J Cancer Prev.
14:1985–1988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:pp. 1020–1022.
2011, View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Li JC, Sun XR, Xu HX, Zhou Y, Qiu J,
Ke SJ, Cui AW, Wang YH, Wang ZJWM, et al: Up-regulation of
Kruppel-like factor 8 promotes tumor invasion and indicates poor
prognosis for hepatocellular carcinoma. Gastroenterology.
139:2146–2157.e12. 2010. View Article : Google Scholar
|
|
13
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou L, Rui J-A, Ye D-X, Wang S-B, Chen
S-G and Qu Q: Edmondson-Steiner grading increases the predictive
efficiency of TNM staging for long-term survival of patients with
hepatocellular carcinoma after curative resection. World J Surg.
32:1748–1756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moffat J, Grueneberg DA, Yang X, Kim SY,
Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK,
et al: A lentiviral RNAi library for human and mouse genes applied
to an arrayed viral high-content screen. Cell. 124:1283–1298. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang B, Halder SK, Kashikar ND, Cho YJ,
Datta A, Gorden DL and Datta PK: Antimetastatic role of Smad4
signaling in colorectal cancer. Gastroenterology. 138:969–980.e1–3.
2010. View Article : Google Scholar
|
|
17
|
Han D, Li SJ, Zhu YT, Liu L and Li MX:
LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer.
Asian Pac J Cancer Prev. 14:4033–4039. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baas AF, Boudeau J, Sapkota GP, Smit L,
Medema R, Morrice NA, Alessi DR and Clevers HC: Activation of the
tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD.
EMBO J. 22:3062–3072. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boudeau J, Baas AF, Deak M, Morrice NA,
Kieloch A, Schutkowski M, Prescott AR, Clevers HC and Alessi DR:
MO25alpha/beta interact with STRADalpha/beta enhancing their
ability to bind, activate and localize LKB1 in the cytoplasm. EMBO
J. 22:5102–5114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
22
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Korsse SE, Peppelenbosch MP and van Veelen
W: Targeting LKB1 signaling in cancer. Biochim Biophys Acta.
1835.194–210. 2013.
|
|
24
|
Dahmani R, Just PA, Delay A, Canal F,
Finzi L, Prip-Buus C, Lambert M, Sujobert P, Buchet-Poyau K, Miller
E, et al: A novel LKB1 isoform enhances AMPK metabolic activity and
displays oncogenic properties. Oncogene. 34:2337–2346. 2015.
View Article : Google Scholar
|
|
25
|
Kim CJ, Cho YG, Park JY, Kim TY, Lee JH,
Kim HS, Lee JW, Song yH, Nam SW, Lee sH, et al: Genetic analysis of
the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer.
40:136–141. 2004. View Article : Google Scholar
|
|
26
|
Pineau P, Marchio A, Nagamori S, Seki S,
Tiollais P and Dejean A: Homozygous deletion scanning in
hepatobiliary tumor cell lines reveals alternative pathways for
liver carcinogenesis. Hepatology. 37:852–861. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie Z, Dong Y, Scholz R, Neumann D and Zou
MH: Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta
is required for metformin-enhanced activation of the AMP-activated
protein kinase in endothelial cells. Circulation. 117:952–962.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie Z, Dong Y, Zhang J, Scholz R, Neumann
D and Zou MH: Identification of the serine 307 of LKB1 as a novel
phosphorylation site essential for its nucleocytoplasmic transport
and endothelial cell angiogenesis. Mol Cell Biol. 29:3582–3596.
2009. View Article : Google Scholar :
|
|
29
|
Zhu H, Moriasi CM, Zhang M, Zhao Y and Zou
MH: Phosphorylation of serine 399 in LKB1 protein short form by
protein kinase Cζ is required for its nucleocytoplasmic transport
and consequent AMP-activated protein kinase (AMPK) activation. J
Biol Chem. 288:16495–16505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patel K, Foretz M, Marion A, Campbell DG,
Gourlay R, Boudaba N, Tournier E, Titchenell P, Peggie M, Deak M,
et al: The LKB1-salt-inducible kinase pathway functions as a key
gluconeogenic suppressor in the liver. Nat Commun. 5:45352014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shaw RJ, Lamia KA, Vasquez D, Koo SH,
Bardeesy N, Depinho RA, Montminy M and Cantley LC: The kinase LKB1
mediates glucose homeostasis in liver and therapeutic effects of
metformin. Science. 310:1642–1646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Evan G and Littlewood T: A matter of life
and cell death. Science. 281:1317–1322. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lowe SW, Cepero E and Evan G: Intrinsic
tumour suppression. Nature. 432:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miyoshi H, Deguchi A, Nakau M, Kojima Y,
Mori A, Oshima M, Aoki M and Taketo MM: Hepatocellular carcinoma
development induced by conditional beta-catenin activation in
Lkb1+/− mice. Cancer Sci. 100:2046–2053. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakau M, Miyoshi H, Seldin MF, Imamura M,
Oshima M and Taketo MM: Hepatocellular carcinoma caused by loss of
heterozygosity in Lkb1 gene knockout mice. Cancer Res.
62:4549–4553. 2002.PubMed/NCBI
|
|
36
|
Maillet V, Boussetta N, Leclerc J, Fauveau
V, Foretz M, Viollet B, Couty JP, Celton-Morizur S, Perret C and
Desdouets C: LKB1 as a gatekeeper of hepatocyte proliferation and
genomic integrity during liver regeneration. Cell Reports.
22:1994–2005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martínez-López N, Varela-Rey M,
Fernández-Ramos D, Woodhoo A, Vázquez-Chantada M, Embade N,
Espinosa-Hevia L, Bustamante FJ, Parada LA, Rodriguez MS, et al:
Activation of LKB1-Akt pathway independent of phosphoinositide
3-kinase plays a critical role in the proliferation of
hepatocellular carcinoma from nonalcoholic steatohepatitis.
Hepatology. 52:1621–1631. 2010. View Article : Google Scholar : PubMed/NCBI
|
